Back to the main directory
Press Release
- Freshpet Advances Operational Improvement Plan with New Talent Addition by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc by EQS Group AG
- NICE Delivers New RPA Innovations leveraging AI To Achieve Complete Performance and Master CXi by BusinessWire
- Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2022 and Initial 2023 Outlook by BusinessWire
- Establishment Labs Announces Preliminary Unaudited Revenue for Fourth Quarter and Fiscal Year 2022 by BusinessWire
- Steve Gorman, Founding Member of The Black Crowes, Heads to the Twin Cities as Morning Host for Cumulus Media’s Classic Rock Station, KQRS-FM by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Devro plc by EQS Group AG
- Editas Medicine Announces Strategic Updates and Portfolio Reprioritization by GlobeNewsWire
- Coherus Agrees to Acquire Exclusive U.S. Commercial Rights to Eylea® Biosimilar FYB203 from Klinge Biopharma by GlobeNewsWire
- Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc by EQS Group AG
- Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates by BusinessWire
- Form 8.3 - The Vanguard Group, Inc.: Biffa plc by EQS Group AG
- Hudson Technologies Ranked No. 5 on Forbes 100 Best Small Companies List for 2023 by GlobeNewsWire
- Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance by BusinessWire
- Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023 by GlobeNewsWire
- Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results by GlobeNewsWire
- Blue Water Vaccines to Present at Biotech Showcase 2023 During the 41st Annual J.P. Morgan Healthcare Conference Week in San Francisco by GlobeNewsWire
- Standard BioTools Provides Preliminary Fourth Quarter 2022 Revenue and Business Update by GlobeNewsWire
- iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference by GlobeNewsWire
- Atreca Appoints Philippe Bishop, MD as Chief Medical Officer by GlobeNewsWire
- Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress by GlobeNewsWire
- Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance by GlobeNewsWire
- CENTOGENE and Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics by GlobeNewsWire
- HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event by GlobeNewsWire
- EQS-News: Familie Schurter gibt Mehrheit der SCHURTER Gruppe in neue Hände by EQS Group AG